{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:16:17Z","timestamp":1756311377924,"version":"3.37.3"},"reference-count":24,"publisher":"Japanese Society of Veterinary Science","issue":"10","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02513"],"award-info":[{"award-number":["22H02513"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1292\/jvms.24-0218","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T22:11:41Z","timestamp":1724710301000},"page":"1100-1104","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of vincristine as a rescue therapy for canine histiocytic          sarcoma"],"prefix":"10.1292","volume":"86","author":[{"given":"Hiroki","family":"SAKUMA","sequence":"first","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary              Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of              Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"TANI","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary              Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of              Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"GOTO-KOSHINO","sequence":"additional","affiliation":[{"name":"Veterinary Medical Center, Graduate School of Agricultural and Life              Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"OHMI","sequence":"additional","affiliation":[{"name":"Veterinary Medical Center, Graduate School of Agricultural and Life              Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"TSUJIMOTO","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary              Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of              Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"TOMIYASU","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary              Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of              Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Asada              H, Tani              A, Sakuma              H,                Hirabayashi              M, Matsumoto              Y, Watanabe              K, Tsuboi              M, Yoshida              S, Harada              K, Uchikai              T,                Goto-Koshino              Y, Chambers              JK, Ishihara              G, Kobayashi              T, Irie              M, Uchida              K, Ohno              K, Bonkobara              M, Tsujimoto              H, Tomiyasu              H. 2023.            Whole exome and transcriptome analysis revealed the activation of ERK and            Akt signaling pathway in canine histiocytic sarcoma. <i>Sci              Rep<\/i>          13: 8512.","DOI":"10.1038\/s41598-023-35813-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Asada              H, Tomiyasu              H,                Goto-Koshino              Y, Fujino              Y, Ohno              K, Tsujimoto              H. 2015.            Evaluation of the drug sensitivity and expression of 16 drug            resistance-related genes in canine histiocytic sarcoma cell lines.              <i>J Vet Med Sci<\/i>          77: 677\u2013684.","DOI":"10.1292\/jvms.14-0415"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Dhyani              P, Quispe              C, Sharma              E, Bahukhandi              A, Sati              P, Attri              DC, Szopa              A,                Sharifi-Rad              J, Docea              AO, Mardare              I, Calina              D, Cho              WC. 2022.            Anticancer potential of alkaloids: a key emphasis to colchicine,            vinblastine, vincristine, vindesine, vinorelbine and vincamine.              <i>Cancer Cell Int<\/i>          22: 206.","DOI":"10.1186\/s12935-022-02624-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Doka              RM, Suter              SE,                Mastromauro              ML, Bennett              AL, Hess              PR. 2022.            Doxorubicin for treatment of histiocytic sarcoma in dogs: 31 cases            (2003-2017). <i>J Am Vet Med Assoc<\/i>          260: 1827\u20131833.","DOI":"10.2460\/javma.21.11.0498"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hawkes              EA,                Barraclough              A, Sehn              LH. 2022.            Limited-stage diffuse large B-cell lymphoma.              <i>Blood<\/i>          139: 822\u2013834.","DOI":"10.1182\/blood.2021013998"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ito              K, Miyamoto              R, Tani              H, Kurita              S, Kobayashi              M, Tamura              K, Bonkobara              M. 2018.            Effect of dasatinib in a xenograft mouse model of canine histiocytic            sarcoma and in vitro expression status of its potential target EPHA2.              <i>J Vet Pharmacol Ther<\/i>          41: e45\u2013e48.","DOI":"10.1111\/jvp.12449"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ito              K, Kuroki              S, Kobayashi              M, Ono              K, Washizu              T, Bonkobara              M. 2013.            Identification of dasatinib as an in vitro potent growth inhibitor of            canine histiocytic sarcoma cells. <i>Vet            J<\/i>          196: 536\u2013540.","DOI":"10.1016\/j.tvjl.2012.12.016"},{"key":"8","unstructured":"8. Kambayashi              S, Minami              K, Ogawa              Y, Hamaji              T, Hwang              CC, Igase              M, Hiraoka              H, Miyama              TS, Noguchi              S, Baba              K, Mizuno              T, Okuda              M. 2015.            Expression of O(6)-methylguanine-DNA methyltransferase causes lomustine            resistance in canine lymphoma cells. <i>Can J Vet              Res<\/i>          79: 201\u2013209."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kezer              KA, Barber              LG, Jennings              SH. 2018.            Efficacy of dacarbazine as a rescue agent for histiocytic sarcoma in            dogs. <i>Vet Comp Oncol<\/i>          16: 77\u201380.","DOI":"10.1111\/vco.12314"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Klahn              SL, Kitchell              BE, Dervisis              NG. 2011.            Evaluation and comparison of outcomes in dogs with periarticular and            nonperiarticular histiocytic sarcoma. <i>J Am Vet Med              Assoc<\/i>          239: 90\u201396.","DOI":"10.2460\/javma.239.1.90"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. LeBlanc              AK, Atherton              M, Bentley              RT, Boudreau              CE, Burton              JH, Curran              KM, Dow              S, Giuffrida              MA, Kellihan              HB, Mason              NJ, Oblak              M, Selmic              LE, Selting              KA, Singh              A, Tjostheim              S, Vail              DM, Weishaar              KM, Berger              EP, Rossmeisl              JH, Mazcko              C. 2021.            Veterinary Cooperative Oncology Group-Common Terminology Criteria for            Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and            cats. <i>Vet Comp Oncol<\/i>          19: 311\u2013352.","DOI":"10.1111\/vco.12677"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Marconato              L, Sabattini              S, Buchholz              J, Polton              G, Finotello              R, Martano              M, Willman              M, Massari              F, Agnoli              C, Gedon              J, Cancedda              S, Campigli              M, Rohrer                Bley              C. 2020.            Outcome comparison between radiation therapy and surgery as primary            treatment for dogs with periarticular histiocytic sarcoma: An Italian Society of            Veterinary Oncology study. <i>Vet Comp            Oncol<\/i>          18: 778\u2013786.","DOI":"10.1111\/vco.12609"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mason              SL, Finotello              R, Blackwood              L. 2018.            Epirubicin in the treatment of canine histiocytic sarcoma: sequential,            alternating and rescue chemotherapy. <i>Vet Comp              Oncol<\/i>          16: E30\u2013E37.","DOI":"10.1111\/vco.12329"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Moore              PF. 2014.            A review of histiocytic diseases of dogs and cats.              <i>Vet Pathol<\/i>          51: 167\u2013184.","DOI":"10.1177\/0300985813510413"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nguyen              SM, Thamm              DH, Vail              DM, London              CA. 2015.            Response evaluation criteria for solid tumours in dogs (v1.0): a            Veterinary Cooperative Oncology Group (VCOG) consensus document.              <i>Vet Comp Oncol<\/i>          13: 176\u2013183.","DOI":"10.1111\/vco.12032"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rassnick              KM, Moore              AS, Russell              DS, Northrup              NC, Kristal              O, Bailey              DB, Flory              AB, Kiselow              MA, Intile              JL. 2010.            Phase II, open-label trial of single-agent CCNU in dogs with previously            untreated histiocytic sarcoma. <i>J Vet Intern            Med<\/i>          24: 1528\u20131531.","DOI":"10.1111\/j.1939-1676.2010.0588.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rau              SE, Barber              LG, Burgess              KE. 2010.            Efficacy of maropitant in the prevention of delayed vomiting associated            with administration of doxorubicin to dogs. <i>J Vet Intern              Med<\/i>          24: 1452\u20131457.","DOI":"10.1111\/j.1939-1676.2010.0611.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Skorupski              KA, Clifford              CA, Paoloni              MC,                Lara-Garcia              A, Barber              L, Kent              MS, LeBlanc              AK, Sabhlok              A, Mauldin              EA, Shofer              FS, Couto              CG, S\u00f8renmo              KU. 2007.            CCNU for the treatment of dogs with histiocytic sarcoma.              <i>J Vet Intern Med<\/i>          21: 121\u2013126.","DOI":"10.1111\/j.1939-1676.2007.tb02937.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Takada              M, Hix              JML, Corner              S, Schall              PZ, Kiupel              M,                Yuzbasiyan-Gurkan              V. 2018.            Targeting MEK in a translational model of histiocytic            sarcoma. <i>Mol Cancer Ther<\/i>          17: 2439\u20132450.","DOI":"10.1158\/1535-7163.MCT-17-1273"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Terwilliger              T, Abdul-Hay              M. 2017.            Acute lymphoblastic leukemia: a comprehensive review and 2017            update. <i>Blood Cancer J<\/i>          7: e577.","DOI":"10.1038\/bcj.2017.53"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tomiyasu              H, Takahashi              M, Fujino              Y, Ohno              K, Tsujimoto              H. 2010.            Gastrointestinal and hematologic adverse events after administration of            vincristine, cyclophosphamide, and doxorubicin in dogs with lymphoma that underwent a            combination multidrug chemotherapy protocol. <i>J Vet Med              Sci<\/i>          72: 1391\u20131397.","DOI":"10.1292\/jvms.10-0176"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tsukamoto              A, Ohno              K, Tsukagoshi              T, Maeda              S, Nakashima              K, Fukushima              K, Fujino              Y, Takeuchi              A, Tsujimoto              H. 2011.            Ultrasonographic evaluation of vincristine-induced gastric hypomotility            and the prokinetic effect of mosapride in dogs. <i>J Vet              Intern Med<\/i>          25: 1461\u20131464.","DOI":"10.1111\/j.1939-1676.2011.00795.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Vail              DM, Rodabaugh              HS, Conder              GA, Boucher              JF, Mathur              S. 2007.            Efficacy of injectable maropitant (Cerenia) in a randomized clinical            trial for prevention and treatment of cisplatin-induced emesis in dogs presented as            veterinary patients. <i>Vet Comp Oncol<\/i>          5: 38\u201346.","DOI":"10.1111\/j.1476-5829.2006.00123.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wouda              RM, Miller              ME, Chon              E, Stein              TJ. 2015.            Clinical effects of vinorelbine administration in the management of            various malignant tumor types in dogs: 58 cases (1997\u20132012).              <i>J Am Vet Med Assoc<\/i>          246: 1230\u20131237.","DOI":"10.2460\/javma.246.11.1230"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/86\/10\/86_24-0218\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T03:45:33Z","timestamp":1728099933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/86\/10\/86_24-0218\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.24-0218","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"type":"print","value":"0916-7250"},{"type":"electronic","value":"1347-7439"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"24-0218"}}